IGC Pharma, Inc. IGC
0.28
0.00
0.00%
as of 25 Sep
- Market cap
- $29.1M
- P/E
- 0.0×
Follow IGC
Growth Flags
show if company had growth for consecutive years
| Mar '16 | Mar '17 | Mar '18 | Mar '19 | Mar '20 | Mar '21 | Mar '22 | Mar '23 | Mar '24 | Mar '25 | |
|---|---|---|---|---|---|---|---|---|---|---|
P/E ratio |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
P/S ratio |
1.34 | 20.78 | 6.88 | 13.97 | 4.75 | 83.65 | 119.63 | 19.62 | 21.00 | 17.55 |
P/FCF ratio |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
P/Operating CF |
(54.03) | (8.67) | (7.81) | (21.47) | (2.23) | (6.95) | (6.36) | (2.54) | (5.43) | (30.55) |
P/B ratio |
0.61 | 1.64 | 1.87 | 2.13 | 0.73 | 2.29 | 1.99 | 1.20 | 3.86 | 3.52 |
Price to Tangible BV |
0.67 | 1.69 | 1.90 | 2.14 | 0.74 | 2.32 | 2.07 | 1.30 | 4.95 | 4.98 |
EV/Sales |
1.26 | 21.42 | 6.32 | 8.99 | 1.85 | 68.00 | 93.65 | 16.25 | 20.31 | 17.44 |
EV/EBITDA |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
EV/Operating CF |
(52.36) | (6.63) | (4.78) | (8.34) | (0.49) | (3.20) | (2.65) | (1.18) | (2.77) | (4.62) |
EV/FCF |
(33.41) | (5.79) | (4.08) | (8.18) | (0.32) | (2.76) | (2.48) | (1.18) | (2.60) | (4.23) |
Quick Ratio |
0.77 | 2.46 | 1.01 | 29.26 | 6.41 | 6.25 | 4.34 | 1.82 | 0.53 | 0.19 |
Current Ratio |
1.20 | 2.78 | 1.37 | 30.44 | 9.12 | 9.93 | 6.19 | 3.41 | 1.58 | 1.28 |
Net Debt/EBITDA |
0.22 | (0.14) | (0.24) | 5.58 | 1.76 | 1.70 | 0.70 | 0.28 | 0.12 | 0.04 |
Debt/Assets |
5.40% | 23.43% | 20.52% | 0.15% | 1.85% | 1.62% | 0.55% | 1.61% | 1.38% | 1.53% |
Debt/Equity |
0.07 | 0.36 | 0.28 | 0.00 | 0.02 | 0.02 | 0.01 | 0.02 | 0.02 | 0.02 |
Asset Turnover |
0.32 | 0.04 | 0.20 | 0.23 | 0.13 | 0.03 | 0.01 | 0.04 | 0.10 | 0.14 |
Operating CF/Net income |
0.06 | 0.75 | 1.08 | 0.81 | 1.19 | 1.23 | 0.50 | 0.61 | 0.40 | 0.67 |
Capex/Depreciation |
(0.17) | (0.37) | (10.58) | (1.02) | (31.01) | (3.23) | (1.14) | (0.12) | (0.74) | (0.72) |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| (19.57%) | (17.53%) | (23.17%) | (19.68%) | (24.34%) | (29.70%) | (52.97%) | (59.30%) | (116.95%) | (104.33%) | |
| (14.33%) | (12.39%) | (16.14%) | (18.08%) | (23.06%) | (27.17%) | (47.90%) | (52.29%) | (96.01%) | (76.37%) | |
ROIC |
(13.48%) | (16.95%) | (13.18%) | (36.22%) | (29.12%) | (29.07%) | (71.01%) | (61.09%) | (97.82%) | (76.81%) |
Return on Tangible Assets |
(36.39%) | (57.53%) | (25.17%) | (12.91%) | (28.58%) | (27.54%) | (67.98%) | (90.02%) | (256.92%) | (184.53%) |
Average Days of Receivables |
55.19 | 473.48 | 92.87 | 5.99 | 11.92 | 71.13 | 114.92 | 42.87 | 10.58 | 9.76 |
Research and Development Expense of Revenue |
0.00% | 0.00% | 6.25% | 24.55% | 24.83% | 103.45% | 586.90% | 379.91% | 280.52% | 287.57% |
Selling, General and Administrative Expense of Revenue |
42.45% | 391.40% | 79.07% | 68.78% | 146.56% | 880.62% | 3,348.11% | 938.75% | 502.45% | 346.97% |
Intangible Assets out of Total Assets |
0.07 | 0.02 | 0.01 | 0.01 | 0.01 | 0.01 | 0.03 | 0.07 | 0.16 | 0.21 |
Share Based Compensation of Revenue |
0.00% | 43.18% | 26.27% | 11.92% | 18.91% | 73.27% | 553.40% | 312.07% | 131.82% | 129.03% |
Graham Net Nets |
(0.13) | (0.03) | 0.03 | 0.36 | 0.79 | 0.27 | 0.26 | 0.23 | 0.04 | 0.02 |
Graham Number |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Earnings Yield |
(32.69%) | (14.89%) | (12.96%) | (6.93%) | (36.73%) | (12.29%) | (32.63%) | (64.71%) | (45.83%) | (30.36%) |
Free Cash Flow Yield |
(2.83%) | (17.82%) | (22.55%) | (7.86%) | (121.81%) | (29.44%) | (31.52%) | (70.28%) | (37.15%) | (23.48%) |
Revenue per Share |
0.39 | 0.02 | 0.08 | 0.14 | 0.10 | 0.02 | 0.01 | 0.02 | 0.02 | 0.02 |
Operating CF per Share |
(0.01) | (0.05) | (0.07) | (0.09) | (0.22) | (0.26) | (0.15) | (0.13) | (0.09) | (0.06) |
Capex per Share |
(0.01) | (0.01) | (0.01) | 0.00 | (0.11) | (0.04) | (0.01) | 0.00 | (0.01) | (0.01) |
Free Cash Flow per Share |
(0.02) | (0.06) | (0.08) | (0.10) | (0.33) | (0.29) | (0.16) | (0.14) | (0.10) | (0.07) |
Cash per Share |
0.09 | 0.09 | 0.06 | 0.72 | 0.31 | 0.35 | 0.21 | 0.06 | 0.02 | 0.01 |
Shareholders Equity per Share |
0.85 | 0.29 | 0.29 | 0.95 | 0.67 | 0.78 | 0.48 | 0.28 | 0.12 | 0.08 |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Book value per Share |
0.85 | 0.29 | 0.29 | 0.95 | 0.67 | 0.78 | 0.48 | 0.28 | 0.12 | 0.08 |
Free Cash Flow |
(0.28) | (1.54) | (2.13) | (3.39) | (13.14) | (12.34) | (8.20) | (7.13) | (5.67) | (5.24) |
Working Capital |
0.64 | 2.29 | 0.86 | 25.85 | 15.81 | 21.15 | 12.67 | 4.57 | 1.37 | 0.64 |
Capital Expenditures |
(0.12) | (0.15) | (0.20) | (0.06) | (4.47) | (1.54) | (0.74) | (0.08) | (0.47) | (0.44) |
Net Current Asset Value |
(1.07) | (0.35) | 0.42 | 25.83 | 15.31 | 20.45 | 12.17 | 4.20 | 1.12 | 0.48 |
EV/EBIT |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Capex to Sales |
0.02 | 0.25 | 0.09 | 0.01 | 1.10 | 1.72 | 1.87 | 0.09 | 0.35 | 0.35 |
Net Profit Margin |
(44.11%) | (321.73%) | (81.44%) | (80.08%) | (179.64%) | (981.18%) | (3,782.37%) | (1,263.01%) | (966.54%) | (560.27%) |
Price to Operating Income |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other line items | ||||||||||
Depreciation/Fixed assets |
0.10 | 0.42 | 0.00 | 0.01 | 0.01 | 0.04 | 0.07 | 0.08 | 0.17 | 0.19 |
Cash ROIC |
(43.94%) | (18.89%) | (67.52%) | (15.56%) | (46.83%) | (45.07%) | (48.93%) | (82.32%) | (102.75%) | (116.68%) |
Accounts Receivable Turnover |
6.51 | 0.68 | 3.35 | 15.94 | 37.53 | 5.83 | 2.65 | 7.85 | 18.42 | 34.82 |
Accounts Payable Turnover |
21.87 | 0.97 | 6.26 | 17.28 | 7.32 | 1.27 | 0.28 | 0.62 | 0.94 | 0.79 |
Inventory Turnover |
12.67 | 0.00 | 6.51 | 13.58 | 1.76 | 0.16 | 0.05 | 0.15 | 0.29 | 0.45 |
Average Days of Payables |
21.85 | 419.84 | 44.61 | 23.36 | 70.29 | 221.32 | 1,763.87 | 412.47 | 461.02 | 494.32 |
Days of Inventory on Hand |
10.71 | 0.00 | 84.03 | 18.16 | 391.57 | 2,547.10 | 6,379.41 | 2,063.15 | 918.46 | 761.35 |
Average Receivables |
0.98 | 0.86 | 0.66 | 0.32 | 0.11 | 0.15 | 0.15 | 0.12 | 0.07 | 0.04 |
Average Payables |
0.25 | 0.37 | 0.34 | 0.29 | 0.54 | 0.62 | 0.73 | 0.76 | 0.65 | 0.83 |
Average Inventory |
0.44 | — | 0.32 | 0.37 | 2.25 | 4.86 | 4.51 | 3.10 | 2.10 | 1.45 |
Average Assets |
19.60 | 15.07 | 11.07 | 22.66 | 31.72 | 32.43 | 31.35 | 22.01 | 13.54 | 9.32 |
Average Common Equity |
14.35 | 10.65 | 7.71 | 20.82 | 30.05 | 29.67 | 28.35 | 19.40 | 11.12 | 6.83 |
Columns are period end dates